Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis

Author response for "Bone Mineral Density in Antiretroviral Therapy‐Naïve HIV‐1‐Infected Young Adults using Depot Medroxyprogesterone Acetate or Non‐Hormonal Contraceptives in Uganda"

10.1002/jbm4.10446/v2/response1 ◽

2020 ◽

Author(s):

Flavia Kiweewa Matovu ◽

Martin Nabwana ◽

Noah Kiwanuka ◽

Delia Scholes ◽

Esther Isingel ◽

...

Keyword(s):

Bone Mineral Density ◽

Young Adults ◽

Bone Mineral ◽

Author Response ◽

Mineral Density ◽

Hiv 1

Depot Medroxyprogesterone Acetate in Teens: A Risk for Bone Health?

PEDIATRICS ◽

10.1542/peds.106.5.1137 ◽

2000 ◽

Vol 106 (5) ◽

pp. 1137-1138 ◽

Cited By ~ 6

Author(s):

Laura K. Bachrach ◽

Tim Cundy ◽

Susan M. Ott

Keyword(s):

Bone Health ◽

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.496155 ◽

2006 ◽

Author(s):

David Hubacher

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Mineral Density ◽

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.486922 ◽

2006 ◽

Author(s):

Kate Curtis

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Mineral Density ◽

Faculty Opinions recommendation of Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727748411.793536806 ◽

2017 ◽

Author(s):

Phillip Hay

Keyword(s):

Oral Contraceptives ◽

Vaginal Microbiome ◽

Combined Oral Contraceptives ◽

A semi‐mechanistic pharmacokinetic model for depot medroxyprogesterone acetate and drug‐drug interactions with antiretroviral and antituberculosis treatment.

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2324 ◽

2021 ◽

Author(s):

Jose Francis ◽

Rosie Mngqibisa ◽

Helen McIlleron ◽

Michelle A Kendall ◽

Xingye Wu ◽

...

Keyword(s):

Drug Interactions ◽

Pharmacokinetic Model ◽

Antituberculosis Treatment

Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of dosing interval. Smit J, Botha J, McFadyen L, et al. Contraception 2004; 69: 3–7

Journal of Family Planning and Reproductive Health Care ◽

10.1783/1471189041261537 ◽

2004 ◽

Vol 30 (3) ◽

pp. 198-198

Author(s):

Judy Murty

Keyword(s):

Dosing Interval ◽

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial

EClinicalMedicine ◽

10.1016/j.eclinm.2021.100800 ◽

2021 ◽

Vol 34 ◽

pp. 100800

Author(s):

Mags Beksinska ◽

Rodal Issema ◽

Ivana Beesham ◽

Tharnija Lalbahadur ◽

Katherine Thomas ◽

...

Keyword(s):

Weight Change ◽

Intrauterine Device ◽

Open Label ◽

Open Label Trial ◽

Copper Intrauterine Device

A Randomized Controlled Trial of Estrogen Replacement Therapy in Long-Term Users of Depot Medroxyprogesterone Acetate

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2002-020874 ◽

2003 ◽

Vol 88 (1) ◽

pp. 78-81 ◽

Cited By ~ 57

Author(s):

Tim Cundy ◽

Ruth Ames ◽

Anne Horne ◽

Judy Clearwater ◽

Helen Roberts ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Replacement Therapy ◽

Estrogen Replacement Therapy ◽

Controlled Trial ◽

Estrogen Replacement ◽

Randomized Controlled

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception did not influence early discontinuation

EClinicalMedicine ◽

10.1016/j.eclinm.2021.100857 ◽

2021 ◽

Vol 34 ◽

pp. 100857

Author(s):

Luis Bahamondes

Keyword(s):

Weight Change ◽

Intrauterine Device ◽

Early Discontinuation ◽

Copper Intrauterine Device